STOCK TITAN

CVS Health Corp - CVS STOCK NEWS

Welcome to our dedicated news page for CVS Health (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on CVS Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CVS Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CVS Health's position in the market.

Rhea-AI Summary
Aetna announces 2024 Medicare products with expanded benefits and options. Highlights include dental, vision, and hearing benefits on every plan, reduced prescription drug costs, and new MA plan options. Aetna estimates 84% of Medicare-eligible beneficiaries will have access to a $0 monthly premium plan. Expanded benefits for Dual Eligible Special Needs Plan (D-SNP) and Extra Help recipients. Aetna will offer new plans for veterans and individuals considering switching to a Medicare Advantage plan. Overall, the plans offer more choices, flexibility, and benefits that matter most to members.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Rhea-AI Summary
CVS Health announces quarterly dividend of $0.605 per share on Common Stock, payable on November 1, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
dividends
-
Rhea-AI Summary
CVS Health appoints Michael F. Mahoney, Chairman and CEO of Boston Scientific, to its Board of Directors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
management
Rhea-AI Summary
Aetna, a CVS Health company, has seen reductions in suicide-related events among its members compared to 2019 baselines. Aetna adult Commercial members have experienced a 16% reduction in suicide attempts, while Medicare Advantage members have seen a 13.7% reduction. Aetna's youth programming has also led to a 13% reduction in suicide attempts among 13-17-year-olds. CVS Health has implemented various programs and partnerships to support suicide prevention efforts for both individuals and healthcare providers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.81%
Tags
none
-
Rhea-AI Summary
COVID-19 vaccine now available at CVS Pharmacy locations
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
covid-19
-
Rhea-AI Summary
CVS Health announces additional responsibilities for executive leadership team
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.37%
Tags
management
Rhea-AI Summary
CVS Pharmacy and MinuteClinic are encouraging consumers to get an annual flu shot and stay up to date on routine vaccinations. They are offering the flu vaccine and the new respiratory syncytial virus (RSV) vaccine at locations nationwide. CVS Pharmacy and MinuteClinic are also preparing to offer a new CDC-recommended COVID-19 vaccine. Appointments can be scheduled in advance using the digital scheduler at CVS.com or in the CVS Pharmacy app. Convenient hours and scheduling flexibility are important factors for patients when choosing where to get a flu shot.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
none
-
Rhea-AI Summary
CVS Health CEO and CFO to participate in fireside chat with investors at Morgan Stanley Global Healthcare Conference on September 12, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
conferences
-
News
Rhea-AI Summary
CVS Health launches Cordavis subsidiary to bring biosimilar products to market, starting with Hyrimoz® at over 80% lower list price than Humira®
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
none
Rhea-AI Summary
CVS Health Corporation® reports Q2 2023 operating results with total revenues of $88.9 billion, up 10.3% YoY. GAAP diluted EPS is $1.48 and Adjusted EPS is $2.21. Full-year 2023 guidance is revised to $6.53 to $6.75 for GAAP EPS and confirmed at $8.50 to $8.70 for Adjusted EPS.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.33%
Tags
CVS Health Corp

NYSE:CVS

CVS Rankings

CVS Stock Data

86.52B
1.25B
0.12%
82.88%
1.8%
Pharmacies and Drug Stores
Retail Trade
Link
US
Woonsocket

About CVS

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands.